20 20 Gene Systems

20 20 GeneSystems, based in Gaithersburg, MD, is a leading life science company specializing in modernizing clinical lab testing through the use of machine learning and real-world data. Their flagship product, OneTest for Cancer, combines the results of six cancer biomarker tests with personal health data and an artificial intelligence algorithm to provide a probability score for various types of cancers, offering a comprehensive and efficient screening solution. Additionally, the company offers Covid-19 testing services to communities and institutions, leveraging their high-complexity CLIA-certified lab to meet the testing needs of the Mid-Atlantic Region.

With a strong focus on innovation and market demand, 20 20 GeneSystems has experienced remarkable success, raising significant capital through equity crowdfunding and reporting record sales. Their dedication to cancer screening and their ability to adapt to new opportunities, such as the Covid-19 pandemic, have contributed to their rapid growth and recognition as one of the fastest-growing privately-owned companies in the nation. Through their commitment to reducing cancer deaths worldwide and their expertise in cancer biomarker test development, 20 20 GeneSystems is making significant strides in the field of clinical lab testing.

Generated from the website